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DISSERTATION ABSTRACT 
During aetiology of respiratory illnesses, it is widely accepted that infection is preceded by 
nasopharyngeal (NP) colonisation with bacteria and that NP flora develop early in childhood 
(during the first year of life). The presence of multiple NP bacteria results in competitive and 
synergistic associations, however temporal organism interactions have rarely been explored 
due to limited availability of longitudinal data sets, and the complex statistical methods 
needed. This study aimed to identify, describe and quantify the temporal interactions existing 
between selected key bacteria colonizing the nasopharynx in young children (up to 1 year 
old), and to further compare these patterns in children who go on to develop pneumonia 
compared to those who do not. 
The significance of the study, as well as the objectives of the study, methods and data 
analysis plan are outlined in the study protocol (Part A). A summary of what is currently 
known about NP bacterial species interactions is presented as part of the literature review 
(Part B). The primary aim of the literature review was to describe the prevalence of NP 
carriage of four NP colonizing bacteria of interest: S. pneumoniae, S. aureus, H. influenzae 
and M. catarrhalis in children, as well as identify any risk factors or confounding 
associations. The literature review furthermore aimed to identify previously described NP 
bacterial species interaction patterns, as well as providing a summary of statistical approaches 
previously employed in the studying bacterial interactions. A manuscript presenting the 
subsequent analysis of these data is included as Part C. 
This study was a secondary data analysis of 760 infants enrolled in a birth cohort with NP 
swabs collected every two weeks for the first year of life and additionally at episodes of 
lower respiratory tract infections (LRTI). Kaplan-Meier estimates were used to visualize time 
to first carriage. Generalised estimating equations with a logit link and adjusted for repeated 
measures were used to estimate the time varying association of NP bacteria carriage with 
development of pneumonia, while enabling adjustment by key confounders. Markov multi 
state models (MSMs) were used to describe NP bacterial acquisition with age and estimation 
of clearance probabilities, new acquisition or persistent acquisition.  
There were 760 individuals included in the analysis, with a total of 16,346 NP samples 
available and a median 364 person-days (IQR 346 – 365 person-days). S. pneumoniae was 
predominant, found in >55% of all samples and demonstrating carriage in >95% of 
individuals at least once by 12 months of age. S. aureus was both less common (25% of 
6 
samples and 88% of individuals) but also had a strikingly different pattern of first acquisition 
compared to the other three organisms, demonstrating a rapid increase in carriage prevalence 
until approximately four weeks and subsequently decreasing.   
S. pneumoniae had the highest co-carriage prevalence overall with H. influenzae and M.
catarrhalis (both 25%) but this varied by age category. In contrast, co-carriage with S. aureus 
was less prevalent with either S. pneumoniae (12%), H. influenzae (5%) or M. catarrhalis 
(6%). Co-carriage frequencies differed considerably by age category, at least partially 
reflecting the relative prevalence of carriage by age. Carriage and co-carriage rates were 
similar among those children that experienced LRTI compared to those that did not. Seasonal 
carriage varied, but to a small extent compared to variance by age.   
Models adjusting for sex, site, season of birth and age found temporally sustained positive 
associations between the co-carriages of S. pneumoniae with H. influenzae, and M. 
catarrhalis, but no association with S. aureus.  
Clear differences occur in the co-carriage patterns of S. pneumoniae with other organisms.  
The probability of acquisition of S. pneumoniae is modified by earlier carriage of H. 
influenzae or M. catarrhalis. Positive H. influenzae carriage increases the probability of 
acquisition of S. pneumoniae with transition probabilities from 0.15 (95% CI 0.14-0.17) to 
0.36 (95% CI 0.17, 0.54) after 28 days of age, compared to the same period probability of 
acquisition of S. pneumoniae alone at 0.015 (95% CI 0.043-0.076) to 0.088 (95% CI 0.075-
0.10). There is no difference in the clearance of S. pneumoniae related to H. influenzae 
carriage, but clearance of H. influenzae before 6 months of age is far less likely if coming 
from a state of co-carriage (probability between 0.04 - 0.07) compared to sole carriage 
(probability 0.23 - 0.12). The only evidence of differences in clearance probability in the 
models investigating S. pneumoniae and M. catarrhalis are in the probability of M. 
catarrhalis clearance before 28d which is 0.24 (95% CI 0.15 - 0.38) if carried alone and only 
0.058 (55%CI 0.01 - 0.30) if carried with S. pneumoniae, though these confidence intervals 
overlap.  
Through this modelling we found positive sustained interactions between S. pneumoniae and 
both H. influenzae, and M. catarrhalis, where models indicated that preceding carriage or 
colonisation with either H. influenzae, and M. catarrhalis may increase the risk of 
colonisation with S. pneumonia.  Timing of carriage and overall prevalence of carriage are in 




H. influenzae, M. catarrhalis during the first year of life and rapid and early exposure to S. 
aureus. Carriage, co-carriage and transition frequency did not vary appreciably when 
comparing children who experienced LRTI in the first year of life compared to those who did 
not, suggesting that overall exposures are similar, but that further modelling is required to 
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Protocol Title: Identifying and quantifying organism interactions in longitudinal child 
health studies. 
Introduction 
In the aetiology of bacterial pneumonia and otitis media (OM), it is generally accepted that 
infection is preceded by nasopharyngeal (NP) colonization (Dunne et al. 2013). Several 
studies support that NP flora develop and establish early in childhood or in first year of life. 
Of the organisms that colonize the nasopharynx (i.e. those that develop and establish), the 
commonly studied are S. pneumoniae, H. influenzae, M. catarrhalis and S. aureus, all of 
which are associated with respiratory disease in children. However, colonization of the 
nasopharynx of young children is often asymptomatic (Murphy et al. 2009), and organism 
colonisation is known to co-occur. Colonisation timing or pattern can be impacted by risk 
factors, antimicrobial treatment and/or vaccination (Xu et al. 2012). 
A body of literature exist on organism interactions, however temporal organism interactions 
have not been explored, especially regarding whether observed colonization patterns are 
resultant of the host’s immunity or synergistic and antagonistic organism interactions. An 
understanding of the time dependent interactions in young children could provide insight into 
interpretation of estimated nasopharyngeal (NP) colonization thresholds and diagnosis of 
respiratory tract infections. 
Research aims and objectives  
The primary aim of this study is to identify, describe and quantify temporal interactions 
existing between selected pathogens occurring in the nasopharynx in young children (up to 1 
year of life), and to compare these patterns in children who have an occurrence of lower 
respiratory tract infection (LRTI) in the first year of life compared to those that do not.  
Specific objectives: 
1. Describe the frequency, seasonality, and age related patterns of S aureus, S 
pneumoniae, H influenzae and M catarrhalis carriage from NP samples in infants less 
than 1 year. 
2. Estimate the direction and magnitude of co-occurrence and temporal interactions 
between S pneumoniae and each of S aureus, H influenzae and M catarrhalis. 
3. Compare the patterns of organism colonisation between infants who have experienced 





Lower respiratory tract infections (LRTI) persist as the leading cause of morbidity and 
mortality in young children with an estimated incidence of about 0.22 episodes per child-year 
in low- and middle-income countries (LMICs) in 2010 (Rudan et al. 2013). Although LRTI 
does not follow a one-cause one-disease postulate, there are known more common disease 
causing organisms. Among pneumonia cases in a South African setting, respiratory syncytial 
virus (RSV) was the most common pathogen followed by influenza, at 29% and 17%, 
respectively. Moreover, the estimated incidence of community acquired pneumonia was 0.14 
(705 554/5 041 132) for all acute lower respiratory infections (LRTI) and 0.4 (203 482/5 041 
132) for RSV related pneumonia in the same setting (Rudan et al. 2013). Among young 
children globally, at least 50% are expected to be colonized with S pneumoniae, H influenzae 
or M catarrhalis at a given point in time and approximately 35% with S aureus (Pettigrew et 
al. 2008). All four organisms are known to cause disease, primarily respiratory tract 
infections, in early childhood, and so represent important species of study. Though organism 
carriage in the nasopharynx (NP) is not necessarily indicative of colonisation, nor of 
progression to disease, carriage is a necessary precursor (Anthony et al. 2012).  
 
Studying carriage risk factors may offer an opportunity to intervene on respiratory disease by 
enabling one to alter or modulate exposure to predisposing factors, especially in pathogenesis 
of respiratory infections. Risk factors for NP colonisation by one organism may be similar or 
different to NP colonisation by other common NP colonisers. For instance, Pettigrew et al. 
(2008) showed that age, race and day care attendance were associated with colonisation by H 
influenzae but not with S pneumoniae or M catarrhalis. In addition to environmental and 
clinical risk factors, another factor that may alter progression to disease is co-occurrence or 
competing occurrence of organisms.  Organism interactions have been studied for years 
including exploration of host, agent and environmental factors, i.e. whether or not these 
predispose one to nasopharyngeal (NP) colonisation and subsequent disease. Lewnard et al. 
(2016) was interested in whether observed organism interactions were a true reflection of 
interspecies interactions or merely just confounded results. Using longitudinal data of 
children aged between 2 – 30 months, the authors arrived at the conclusion that observed 
organism interactions are more likely to be due to interspecies interaction rather than simple 




Previous work (Heinsbroek et al. 2015) has reported distributions in carriage of S 
pneumoniae among infants by maternal HIV exposure status (no difference), age (64.7% at 
14 weeks of age compared to 27.1% at 52 weeks of age) and season (August peak), using 
longitudinal household data. Similarly, both S. pneumoniae and H. influenzae carriage have 
been report to peak during winter seasons (Lewnard et al. 2016). Further work by Lewnard et 
al. (2016) investigating possible confounding in analysis of organism interactions, found no 
confounding by age or season, but potential confounding by differences in socio-economic 
status (SES). In their data, investigators found that among a low SES population both S 
pneumoniae and H influenzae acquisition was earlier and with higher overall prevalence than 
compared to a high SES population at two months of age, noting that the groups came from 
different cultural backgrounds. Co-colonisation with S. pneumoniae and H. influenzae 
resulted in a 25% greater decline in S. aureus carriage in the children from the low SES 
households compared to the high SES households (Lewnard et al. 2016). 
 
A number of studies investigating NP organism interactions have been done, but often 
describe contradictory findings (Murphy et al. 2009).  Authors have described synergism 
between S. pneumoniae + H. influenzae and antagonism between both S pneumoniae + S 
aureus and H. influenzae + S aureus (Lewnard et al. 2016). Pettigrew et al (2008), however, 
describe an antagonistic association between H influenzae and S pneumoniae. Although there 
are slight age differences in the children between the studies, that alone does not appear to 
sufficiently explain the different findings. Further, the results suggest that additional 
organisms, for example, considering co-colonisation by M catarrhalis, substantially 
increased the complexity of evaluation. In Pettigrew et al (2008), it was found that when M 
catarrhalis co-colonised with H influenzae the antagonism between H influenzae + S 
pneumoniae reversed to synergism. Inverse associations were also observed between both S 
pneumoniae and H influenzae individually with S aureus (Pettigrew et al 2008). The degree 
of complexity in understanding even interactions between a few organisms calls for careful 
longitudinal studies and considered analysis.  
 
Most of the literature estimating organism interactions are cross sectional study designs, with 
only a handful being longitudinal or repeated measures designs (Jacoby et al. 2007; Pettigrew 
et al. 2008; Rupa et al. 2012). While longitudinal designs have obvious strengths in assessing 
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temporal organism interactions, accounting for the variance from repeated individual 
participant samplings (i.e. serial observations or correlation) is important. Previously applied 
methods have varied, but primarily have been focused on generalized estimating equation 
(GEE), a ‘population-averaged’ model. For example, Pettigrew et al., (2008) followed infants 
6 – 36 months old for a period of 1 year and used a GEE framework under a repeated 
measures logistic regression with an autoregressive correlation structure to estimate 
population odds ratios. Similarly, Rupa et al. (2012) modelled longitudinal data accounting 
for serial observations through an exchangeable correlation structure, again using a 
GEE framework. Unlike the GEE marginal models, Jacoby et al. (2007) applied a 
conditional multivariable mixed effects models to estimate pairwise interactions.  Apart 
from GEE, exploratory analysis computing carriage frequencies are part of the early 
literature on NP colonisation and organism interactions. With cross-sectional data, 
interactions are typically estimated by unadjusted odds ratios from chi-squared test or 




This data for this secondary analysis is taken from the Drakenstein Child Health Study 
(DCHS) (Zar et al. 2014).  DCHS is a population-based birth cohort study investigating early-
life determinants of child health. Mother-infant pairs were enrolled at the time of infant birth 
and followed longitudinally for five years. The DCHS cohort includes >1000 mother-infant 
pairs, and follow-up is ongoing. The enrolled participants attended routine study visits 
at scheduled time points as well as unscheduled visits during sick episodes. A subset of 
the cohort elected to be enrolled into an intensively sampled group, who underwent 2-
weekly visits during the first year of life. The samples for this analysis are from the 
intensively sampled sub-cohort.  
Characteristics of the study population 
The DCHS parent study recruited pregnant mothers in their second trimester a from peri-
urban area in Cape Town, characterized by low socio-economic status (SES), informal 
housing, crowding and a high unemployment rate (Zar et al. 2015). Neonates and their 
mothers are followed for at least 5 years with some enrolled into an intensively sampled early 
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life cohort. Children received PCV13 and Hib immunizations from the primary health care, 
which are part of the South African routine immunization programme with the majority 
(>99%) of children receiving the full course of vaccination. HIV prevalence among mothers 
is 25% with only 2 HIV infected children (Zar et al. 2013). 
Recruitment and enrolment 
Research procedures and data collection methods 
This study investigates selected measures from the subset of >800 infants participating in an 
intensively measured cohort during the first year of life. Study visits were conducted by 
trained study staff and data entered into REDCap database using standardised case report 
forms (CRFs). Primary outcome measures are from nasopharyngeal (NP) swabs that were 
taken at both routine study visits (every 2 weeks) and at episodes of lower tract respiratory 
infection (LRTI) identified by active surveillance. Collected NP swabs (Copan flocked swab, 
FLOQSwabsTM, COPAN Diagnostics, Murrieta, CA, United States) were immediately 
placed into 1ml skim milk-tryptone-glucose-glycerol (STGG), transported at 4 °C to the 
laboratory within 2hours of collection and frozen at −80 °C for later batch culture. Swabs 
were inoculated onto Mannitol Salt Agar (MSA) (National Health Laboratory Services, 
Green Point Media Laboratory Cape Town, South Africa) and incubated at 35◦C for 18–24h 
in room temperature air prior to measurement. The presence or absence of the S aureus, S 
pneumoniae, H influenzae and M catarrhalis in culture results, as well as the date of the 
sample, the infant date of birth, and a few key clinical or demographic parameters including 
sex, site, and date of LRTI are included in the set of analysis measures.   
Data analysis 
The opportunity to work on a very densely sampled cohort provides different possible study 
designs. In the first instance infants will be categorised in two groups, those who developed 
pneumonia in the first year and those that did not, and the prevalence and pattern of 
colonisation of the four identified organisms will be described. Kaplan-Meier and time to 
event methods will be used to describe time to first organism acquisition.  
To describe the pairwise temporal interactions Chi-squared and Fisher’s exact tests will be 
used to estimate the odds ratio (OR) of positive-positive interaction between pairs of visits, 
versus no association or positive-negative interaction. This preliminary exploration will need 




Generalised estimating equations (GEE) or binomial models for repeated measures will be 
used to estimate the time varying association of organism colonisation with the development 
of pneumonia, while enabling adjustment by key confounders. 
Multi-state models will be developed to estimate the probability of state transitions where 
states are defined by the presence or absence of specified organisms in a given sample. 
Research feasibility  
The DCHS parent study has been approved by all appropriate ethics boards and permission to 
use a sample from the data has been granted. My proposed supervisor has experience with the 
proposed methods and is a regular collaborator with the DCHS PIs (Prof H Zar and Prof M 
Nicol). 
Description of risks and benefits  
As this is a secondary analysis of data that has already been collected and de-identified, there 
are no direct risks or direct benefits to participants in this study. There is a small risk of loss 
of confidentiality due to the presence of personal data. There are anticipated general benefits 
as the work may help inform the pattern and role of key organisms in early life in association 
to lower respiratory tract infection.  
Informed consent process  
Written informed consent in the parent study was obtained from mothers and renewed 
annually. Additional consent was obtained from fathers, as identified by mothers, when 
possible. The DCHS received ethical approval from Human Research Ethics Committee 
(HREC), Faculty of Health Sciences University of Cape Town, Stellenbosch University and 
the Western Cape Provincial Research Committee. 
Privacy and confidentiality  
The privacy of participants is ensured in the analysis as the sample dataset has been de-
identified by the DCHS data management team. No personal participant identifiers such as ID 
numbers or names are available to researchers. Study data will further be maintained on a 




Dissemination of research findings  
The findings will submitted as a mini-dissertation in partial fulfilment of the Masters of 
Public Health degree from the University of Cape Town and may also be submitted for 
publication in a peer reviewed journal.  
Public health significance  
In addition to the benefits alluded to in the problem identification section above, an 
understanding of underlying temporal organism interactions in the nasopharynx may help 
predict how novel vaccines against these pathogens may influence the ecology in this niche. 
It may also provide an avenue for design of more effective strategies to combating respiratory 
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Literature review objectives 
The objectives of this literature review are to:  
1. Describe the prevalence of nasopharyngeal carriage of four bacterial species 
(Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae and 
Moraxella catarrhalis) in children in low- and middle-income countries, and explain 
any identified risk factors or confounding associations.  
2. Identify and describe any organism interactions between the bacterial species.   
3. Summarise statistical methods that have been applied previously to estimate either 
magnitude of, or direction of, organism interactions. 
 
Search strategy 
A search for relevant literature on organism interactions and nasopharyngeal carriage was 
conducted in PubMed in September 2018 using syntax constructed around the following 
search terms: upper respiratory tract; lower respiratory tract; Streptococcus pneumoniae; 
Haemophilus influenzae; Moraxella catarrhalis; Staphylococcus aureus; colonisation; 
children; interactions; pneumonia; nasopharyngeal colonisation. 
Summary of the literature 
The search resulted in 34 full papers which were reviewed. The search methodology is 
summarised in Supplement Figure 1 (Appendix) and further details are available in 
Supplement Table 1 (Appendix) 
Bacterial nasopharyngeal carriage and risk factors  
Variable nasopharyngeal (NP) carriage rates have been reported across different studies of 
varying populations, with the child’s age appearing to modify carriage most strongly [1-13]. 
In a US cohort of children aged 6 - 36 months old [1], NP carriage prevalence per organism 
was 46% for S. pneumoniae, 7% for S. aureus, 32% for H. influenzae and 63% for M. 
catarrhalis. The authors of this study indicated that M. catarrhalis and S. aureus carriage was 
considerably below expected prevalence. Among Kenyan children between the ages of 12 – 
59 months old, 50% of children who carried S. pneumoniae also co-carried H. influenzae [4]. 
Another Kenyan study which enrolled children between the ages of 3 - 59 months 




children younger than 12 months of age (where NP samples were taken bi-weekly for the first 
six months of life and bi-monthly for remainder of the year) estimated that overall carriage 
rates of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis were 78%, 20%, 71% and 
70%, respectively [6]. A similar study in Gambia [7] which enrolled children aged two 
months living in a peri-urban area, the carriage rates of S. pneumoniae, S. aureus, H. 
influenzae and M. catarrhalis were 62%, 50%, 30% and 32%, respectively. In Cape Town, 
South Africa among children who were characterised by poor socio-economic status, the 
overall carriage rate for H. influenzae was 46%, which was similar to the carriage rate 
estimated in children less than 12 months old at 44% [8]. A more recent study based in Cape 
Town on children with a median age of 36 months old and with suspected pulmonary 
Tuberculosis, the carriage rate of S. pneumoniae, S. aureus and M. catarrhalis were 42%, 
22% and 64%, respectively [9]. Outside of sub-Saharan Africa, a Brazilian cohort of children 
5 years or younger, of whom 53% had community acquired pneumonia the carriage rate of S. 
pneumoniae was 55% [10]. These data are summarised in Table 1. 








































SP (%) 46% 30% - 66% 78% 62% - 42% 
SA (%) 7% - - - 20% 50% - 22% 
HI (%) 32% 12% - - 71% 30% 46% - 
MC (%) 63% 36% - - 70% 32% - 64% 
SP and HI 
co-carriage 
- - 50% - - - - - 
 1 and 2 indicates 2 different studies in the same country. SP – S_pneumoniae; SA - S. aureus;       
HI - H. influenza; MC - M. catarrhalis 
 
A number of risk factors have been identified in children that are typically thought to be 
associated with organism carriage. These risk factors may include a social context, for 
example, day care attendance or the number of young children in a household. Clinical 
indicators may include a previous or current illness, as well as demographics, sex and age. In 
children aged 1 - 6 years old who had prior experience of penicillin-resistant S. pneumoniae 
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(PRSP) infection and who attended daycare, gender was not associated with any bacterial 
colonisation by either S. pneumoniae, S. aureus, H. influenzae or M. catarrhalis. 
Age, however was associated with colonisation by M. catarrhalis while cumulative time 
spent at the daycare centre was associated with colonisation by H. influenzae [11]. A 
similar lack of association between S. pneumoniae colonisation and gender was shown in 
children less than 5 years, in a Brazilian study [10]. This study showed that 
overcrowded housing was an important risk factor for S. pneumoniae colonisation 
especially in those individuals with a prior community acquired pneumonia. However, 
crowding, method of cooking and tobacco exposure were not associated with S. 
pneumoniae, S. aureus, H. influenzae or M. catarrhalis carriage in Venezuela, but were 
instead associated with poor nutrition [12]. In South African children hospitalised with 
Tuberculosis, those from a poor socio-economic background experienced higher rates of 
colonisation by H. influenzae compared to children from higher socio-economic 
backgrounds [11]. Among HIV-exposed neonates in Tanzania who had not received any 
pneumococcal conjugate vaccine (PCV), S. aureus colonisation was more prevalent in 
HIV-infected children compared to HIV-uninfected children. The converse applied for 
S. pneumoniae colonisation [15]. Moreover, the same study indicated that at 6 weeks of 
life colonisation by S. aureus was associated with urban area and having siblings younger 
than 10 years old. In contrast, at 6 months old only HIV infection remained 
associated with S. aureus colonisation [13]. This suggests that risk factors for S. 
aureus colonisation may be age dependent. Furthermore, at 3 months of age 
colonisation by S. pneumoniae and H. influenzae was associated with having siblings 
younger than 10 years old and colonisation by M. catarrhalis was associated with breast-
feeding [13]. In preschool children aged 2 – 5 years old who had received 
antibiotics before undergoing an adenoidectomy for recurrent upper respiratory tract 
infections (URTIs), colonisation by at least one bacterial species (of S. pneumoniae, S. 
aureus, H. influenzae and M. catarrhalis) was associated with female gender and area 
of residence. Risk factors associated with individual bacterial colonisation included 
rural residence which was associated with a reduction in prevalence of S. pneumoniae; 
passive smoking and daycare attendance were associated with an increase in H. influenzae; 
female gender associated with an increase in M. catarrhalis; and residing in a rural area were 
associated with an increase in S. aureus [14]. 
Some studies have explored carriage rates specifically by disease status. Among children in 
South Africa younger than 5 years old, with Acute Otitis Media (AOM) the carriage rates of 
S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis were 20%, 16%, 31% and 5%,
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respectively [15].  These results were from cultured middle ear fluid samples rather than NP 
samples. In a much older cohort of children, median age 8.4 years old, who had a current 
lower respiratory tract infection (LRTI), NP carriage rates of S. pneumoniae, S. aureus, H. 
influenzae and M. catarrhalis were respectively 17%, 18%, 32% and 27% [16]. In a study of 
children 6 - 36 months old where NP samples were mostly collected within 7 days of an 
upper respiratory infection the overall carriage rates of S. pneumoniae, S. aureus, H. 
influenzae and M. catarrhalis were 46%, 7%, 32% and 63%, respectively [1].  The majority 
(96%) of these children had received at least one dose of PCV7 (vaccination available at time 
of research) at the time of study enrolment with as many as 95% not taking any antimicrobial 
drugs.  
In Tanzania, HIV exposed neonates (six weeks old) of whom none had received any PCV, 
overall carriage rates of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis as 56%, 
66%, 14% and 50%, respectively [13]. In healthy six month old children from USA [1], 
followed up until they were 24 months old, who had all received a dose of PCV-7 and other 
age appropriate vaccinations but no antimicrobial therapy, the carriage rates of S. 
pneumoniae, H. influenzae and M. catarrhalis were 30%, 12% and 36% respectively (see 
Table 1). Children with AOM had carriage rates of 53%, 48% and 43% respectively [17]. 
Moreover, the overall carriage rate by at least one of these bacterial species at healthy vs. at 
AOM visits were 57% vs. 90% [17] which suggests that the rate of NP bacterial colonisation 
can be expected to be higher in ill infants than in healthy children. These data are summarised 
in Table 2.  
























S. pneumoniae 20% 17% 46% 56% 53% 
S. aureus 16% 18% 7% 66% - 
H. influenzae 31% 32% 32% 14% 48% 
M. catarrhalis 5% 27% 63% 50% 43% 






Healthy children may have a different set of risk factors compared to children with either a 
current or previous respiratory infection. In healthy Kenyan children of ages 3 – 59 months 
old who did not receive any pneumococcal vaccination, colonisation by S. pneumoniae was 
negatively associated with previous antibiotic use [5]. Meanwhile in Indonesian children aged 
12 – 24 months old, the child’s region of residence was associated with colonisation by S. 
pneumoniae and M. catarrhalis [17].  Furthermore, Israeli children <40 months old who did 
not receive any pneumococcal vaccination demonstrated that colonisation by S. pneumoniae 
was associated with their daycare attendance, having younger siblings and that they were 
older than 3 months; these three risk factors were all negatively associated with being 
colonised by S. aureus [18]. Although, maternal colonisation by S. aureus was associated 
with the child’s subsequent colonisation by S. aureus, this was however not true for maternal 
carriage of S. pneumoniae and its subsequent colonisation in the child [18]. Staphylococcus 
aureus colonisation in children <6 months was not associated with either breastfeeding or the 
number of siblings [19].  
Conjugate vaccine association with bacterial carriage before and after 
vaccination  
A burden of disease related to vaccine-type S. pneumoniae persists in low- and middle-
income countries (LMICs) despite certain serotypes of S. pneumoniae being effectively 
prevented by pneumococcal conjugate vaccine (PCV) PCV7, 9 and 13 [20]. The widespread 
introduction of PCVs raised some concerns over the possibility of a subsequent increase in S. 
aureus carriage and related disease post PCV vaccination [21]. This was due to the discovery 
of a negative association between S. aureus and S. pneumoniae [21]. Serotype replacement 
has been highlighted as one of the threats to conjugate vaccines, i.e. a biological phenomenon 
where NP colonisation by non-vaccine serotypes occurs post PCV vaccination. This risk 
might be heightened in neonates given the general consensus that NP flora develop in the first 
year of life and S. aureus carriage is typically highest among neonates. Risk generally 
declines with age. In South Africa, all children are expected to receive PCV and Hib 
vaccinations as part of the national immunisation programme. Hib is almost two decades old 
in the South African routine immunisation programme with PCV13 almost a decade old [22].  
A number of studies have investigated the effects of the conjugate vaccines on NP carriage. 




aureus carriage rates [21].  A study compared children aged 12 – 59 months who received 2 
doses of pneumococcal non-typeable H. influenzae protein-D conjugate vaccine (PHiD-CV) 
to children of the same age who received 2 doses of Hepatitis A vaccine, and showed that 
there was no significant increase in the carriage of NP bacteria such as S. aureus or M. 
catarrhalis due either to serotype replacement or the negative association between bacterial 
species [4]. Moreover, there was no increase in the carriage of S. pneumoniae or H. 
influenzae in either treatment group [4]. However, a different conclusion was reached by Van 
Gils et al. (2011) who showed that children who received a 2+1 dose of PCV (at the ages of 
2, 4 and 11 months) there was evidence of temporary increase in S. aureus carriage at the age 
of 12 months while in the control treatment group (those who did not receive any PCV) there 
was a monotonic decrease in S. aureus carriage [23]. 
In Israel, children <40 months of age who had not been vaccinated with PCV, a negative 
association between vaccine-type strains of S. pneumoniae and colonisation by S. aureus was 
observed, additionally S. aureus carriage was higher in S. pneumoniae non-carriers compared 
to carriers and S. pneumoniae carriage was higher among S. aureus non-carriers compared to 
carriers [18]. Although a temporary increase in S. aureus was observed after adjusting for age 
[24], the authors argue that such an increase was not sufficient to support the hypothesis of an 
increase in S. aureus carriage post PCV vaccination due to the negative association between 
S. aureus and vaccine-type S. pneumoniae. 
In South African children with AOM (3 months - 5 years) there was no significant difference 
in middle ear fluid carriage rates of S. pneumoniae and H. influenzae in those children who 
received a PCV7 dosage and those who did not [15]. Also, the number of PCV7 doses 
received by the child were not associated with nasal carriage of S. pneumoniae, vaccine-type 
and nonvaccine-type, or S. aureus in children aged between 6 weeks and 4 years [24]. 
Furthermore, even after adjusting for age, there was a temporary increase in S. aureus 
although this was found to be not sufficient to support the hypothesis that S. aureus carriage 
would increase after vaccination with PCV7 [24].. 
Madhi et al. (2007) investigated the long term effects of PCV on NP colonisation by S. 
pneumoniae among both HIV-infected and uninfected South African children, and the 
interactions between pneumococcus species with other respiratory pathogens. Findings 
suggested that PCV9 and PCV13 increased NP colonisation by non-vaccine serotypes and 




age 5.3 years) PCV was ineffective in reducing NP colonisation after 3 primary doses [22]. 
High S. pneumoniae and H. influenzae colonisation among HIV-infected South African 
children suggested that the burden of pneumococcal disease might be high among HIV 
infected children during periods of increased NP colonisation [25]. 
In a PCV7 dosing trial among 2 -30 months old children, the observed NP carriage rate of S. 
pneumoniae was 70% [21], while in children aged 6 weeks - 4 years old who attended 
daycare, of whom only a minority (27%) had received at least 1-dose of PCV7, the carriage 
rates for S. pneumoniae were 37% and 20% for S. aureus - however samples were nasal and 
not NP [24]. In contrast, children of mean age 5.3 years who had all received at least 1 dose 
of PCV9, the overall carriage rate of S. pneumoniae, S. aureus and H. influenzae were 54%, 
35% and 57% respectively although carriage rates were significantly higher in HIV-infected 
children - 72% for S. pneumoniae and 74% for H. influenzae [25].These data are summarised 
in Table 3. 
Table 3. PCV vaccination and subsequent carriage rate 
Bacteria specific 
prevalence 
Number of doses and study participants’ age characteristics 
PCV7 dosing trial, 
2-30 months old 
PCV7 - at least 1 dose 6 
weeks – 4 years old 
PCV9 -at least 1-dose mean 
age 5,3 years old 
S. pneumoniae  70% 37% 54% (72% among HIV-
infected infants) 
S. aureus - 20% 35% 
H. influenzae  - - 57% (74% among HIV-
infected infants) 
M. catarrhalis - - - 
 
Organism interactions  
In Gambia among children <12 months old, positive interactions were observed between 
colonisation by S. pneumoniae with H. influenzae and M. catarrhalis; while a negative 
interaction between the colonisation by S. pneumoniae and S. aureus were observed [6]. 
Furthermore, it was noticed that there was an early colonisation by H. influenzae and M. 
catarrhalis which also frequently were co-carried alongside S. pneumoniae. In Sweden 
among children 1 – 6 years old, who experienced a penicillin-resistant S. pneumoniae there 




which decreased with age [11], while in this and a USA cohort, a negative interaction was 
observed between S. pneumoniae and H. influenzae, which became positive when H. 
influenzae co-colonised with M. catarrhalis [11, 1]. 
Meanwhile in Peruvian Andes children a positive interaction between colonisation by S. 
pneumoniae and H. influenzae and a negative interaction between colonisation by S. 
pneumoniae and S. aureus was seen [26].  A study distinguished between two levels of 
interactions [27], namely host (between subjects associations) and microbe (within subjects 
associations) and generally at both levels positive pairwise interactions were seen between S. 
pneumoniae, H. influenzae and M. catarrhalis. 
Furthermore, among healthy Indonesian children of ages 12 – 24 months old, findings 
showed positive interactions between S. pneumoniae and H. influenzae, and between H. 
influenzae and M. catarrhalis; a negative interaction between S. aureus and M. catarrhalis 
was recorded [17]. In younger children, aged 6 – 12 months, positive interactions were 
observed between S. pneumoniae with H. influenzae and M. catarrhalis, and a negative 
interaction was observed between colonisation by S. pneumoniae and S. aureus [28]. 
Additionally among healthy 6 -24 months old children, a positive interaction between 
colonisation of S. pneumoniae and M. catarrhalis, and a negative interaction between 
colonisation by S. pneumoniae and S. aureus was recorded, while those study participants 
who acquired AOM demonstrated negative interactions between colonisation by S. 
pneumoniae and H. influenzae and between colonisation by H. influenzae and M. catarrhalis 
[15]. Preschool children 2 – 5 years old, who had received antibiotics before undergoing an 
adenoidectomy for upper respiratory tract infection (URTI), were found to have bacteria in 
the NP which were not associated with bacteria from the adenoidectomy surgical process, 
although in the adenoids there was a positive interaction between colonisation by S. 
pneumoniae and H. influenzae [16].  
Furthermore, in children aged 6 weeks - 4 years, colonisation by S. pneumoniae (vaccine-type 
and non-vaccine-type) were negatively associated with colonisation by S. aureus [24]. 
Children (mean age 5.3 years)who had received at least 1 dose of PCV9 and who were also 
HIV-infected,  showed that S. aureus interacted negatively with S. pneumoniae and H. 
influenzae [25]. Streptococcus pneumoniae interacted positively with colonisation of H. 




It has been suggested previously through a review of clinical studies that the community of 
bacteria in the upper respiratory tract is altered by respiratory viruses, and that respiratory 
viruses may promote bacterial colonisation of the lower respiratory tract [29]. It is generally 
understood that viral infections precede or predispose one to subsequent bacterial 
superinfections (or later co-infections) [30], given this, Murphy et al. (2009) reviewed studies 
of interactions between upper respiratory tract viruses and NP pathogens in relation to 
pathogenesis of upper respiratory tract infections (URTIs). These researchers observed 
synergism between respiratory viruses and NP bacteria. A study of Australian Aboriginal and 
non-Aboriginal children [27] looked at interactions between respiratory bacteria and 
rhinovirus and adenovirus both of which both are associated with otitis media (OM). At 
pathogen/microbe level, rhinovirus showed association with S. pneumoniae, H influenzae and 
M catarrhalis while adenovirus showed association only with M. catarrhalis colonisation 
[27]. 
Meanwhile among children of ages 6 – 12 months old, NP colonisation of S. pneumoniae was 
positively associated with human rhinovirus and enterovirus; colonisation by H. influenzae 
was positively associated with human rhinovirus and respiratory syncytial virus; colonisation 
by M. catarrhalis was positively associated with coronavirus and adenovirus; and 
colonisation by S. aureus was positively associated with influenza viruses [28]. In South 
African children with AOM aged 3 months - 5 years old, about 77% - 79% of children in the 
study had NP colonisation by at least one virus, accompanied by a co-carriage with either S. 
pneumoniae, H. influenzae or M. catarrhalis sampled from middle ear fluid. Additionally, 
colonisation by S. aureus was detected alongside at least one virus from the NP in 63% of the 
study participants [15]. 
Previously applied statistical methods  
As the summary of relevant literature indicates, a majority of the studies investigated NP 
carriage or colonisation from cross-sectional data. Cross-sectional studies are typically 
limited in the statistical methods that can be applied to analyse longitudinal data, and are 
unable to ascertain the temporality of carriage and co-carriage events.  
A review of the literature revealed that the most common method of analysis was logistic 
regression which was used to estimate pairwise bacterial interactions with outcome variable 
as binary bacterial colonisation status [17]. Additionally, interaction estimates between pairs 




whenever statistically appropriate [31] with one bacterial species colonisation as the outcome 
variable and the other species as the exposure variable.  
Interpretation of such an interaction is the same as the ordinary interpretation of the OR, with 
OR > 1 taken to be an indication of a positive interaction and OR < 1 to be an indication of a 
negative interaction [31, 32]. However, Suzuki et al. (date) highlighted concerns about an 
approach using ORs to indicate organism interactions, and they advise that potential 
differences in risks of enrolment for colonisation-positive and colonisation-negative 
individuals should be incorporated into the computation of such ORs, especially for case-
control studies.  They argued that unless a population based cross-sectional study is used, one 
could anticipate a different enrolment risk for sick or healthy children. A further criticism of 
this approach is that unadjusted ORs are insufficient since each pairwise comparison may 
depend on interactions with yet other organisms [32]. 
Longitudinal designs allow for other approaches. The most common approach to exploring 
bacterial interaction in longitudinal studies were population averaged or marginal models 
known as generalised estimating equations (GEE). GEEs have been used for fitting both 
univariate and multivariate logistic regression models with bacterial carriage coded as a 
binary outcome (presence/absence) [1, 21, 31]. The main difference in these studies were the 
choices of correlation structure and that of covariates for adjustment in the multivariable 
models. While GEE models allow for efficient adjustment for correlated data, they do lead to 
population averaged estimates of association which may not be desired in all contexts.   
A few studies fit conditional multivariable mixed effects models [27] to estimate associations 
between pairs of bacterial species. These models fit two random components, distinguishing 
between microbe level correlations and host level correlations, where microbe level 
represents within-subject correlations and host level represents between-subjects correlations. 
It has been argued that such a model has an advantage over analysing longitudinal data cross-
sectionally because it accounts for correlations in repeated observations from the same study 
participant and is also  capable of differentiating between within-level and between-level 
correlations. 
Another method identified in longitudinal studies that was used to understand bacterial 
colonisation in terms of acquisition, clearance and change of state hazard rates, was the 
Markov transition model [33]. Lipsitch et al.(2012) used such a model to understand 
transitions of  multiple S. pneumoniae serotypes with acquisition defined as any transition 
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from state 0 (not colonised with S. pneumoniae) to state i (any of the other S. pneumoniae 
serotypes), and with transition specific hazard rate and clearance defined as any transition 
from state i (resident state) to state 0. Similarly change of serotype could be specified as any 
transition from state i to state j (challenge state). With such a model approximating n2+n 
independent rates and to reduce dimensionality, the authors [33] decided to fit four separate 
models each estimating 2n acquisition and clearance rates but limiting the change of states. 
Limitations of the model were acknowledged as assumptions that transition hazards are 
constant for each of the transitions, and that homogeneity of hosts may not reflect reality, 
considering for example that age is known to be a strong influence for clearance. Their model 
also did not adjust for simultaneous carriage of multiple serotypes.  
Finally, it is worth drawing attention to the possibility of measurement error which may 
depend on the method used to identify the organisms. Differences in yield of bacteria arising 
from detection by culture or by polymerase chain reaction (PCR) are expected, and a number 
of studies have contrasted the disparity in yield of bacteria from these methods. For instance, 
in a study of children in their first year of life, the carriage rates of S. pneumoniae, S. aureus, 
H. influenzae and M. catarrhalis were all much higher in PCR samples compared to 
biological   culture samples [26, 34]. 
Discussion 
Interactions between disease-causing organisms is important from a public health point of 
view. Although the seven studies I reviewed are not really enough for accurate country to 
country comparisons, there were indications that S. pneumoniae carriage or colonisation is 
typically high in all geographic areas varying between 30-78%. The carriage pattern for S. 
pneumoniae suggests its prevalence might be high in infants after which it declines to 
moderate colonisation when the child is 24 months (median age). S. aureus carriage patterns 
suggest that carriage is at least moderate in younger children i.e. 50% in 2 months old infants 
thereafter decreasing with age. The carriages patterns of H. influenzae and M. catarrhalis 
suggest moderately low carriage at younger age namely 12% for H. influenzae in children 
younger than 24 months of age (in USA) and 32% for M. catarrhalis among 2 months old 
infants (in Gambia) rising to approximately 70% in children <12 months old. 
Data, as shown in Table 2 suggest that colonisation by H. influenzae is independent of 




of S. pneumoniae and M. catarrhalis are relatively higher in children with other concomitant 
health conditions such as upper respiratory infections and  acute otitis (AOM) and in HIV-
exposed infants, compared to those with lower respiratory tract infections and AOM 
(recovered from middle ear fluid samples rather than NP). 
In Table 3, these data are not sufficient to support or refute the hypothesis of S. aureus 
increase post PCV vaccination by number of doses, however the PCV9 vaccine seem to be 
less effective among HIV-infected infants.  
Positive interactions have been reported between S. pneumoniae and M. catarrhalis, while 
both positive and negative interactions have been reported with H. influenzae and S. 
pneumoniae. Positive interactions were recorded whenever H. influenzae and M. catarrhalis 
co-occurred. Among children with AOM, negative interactions have been described between 
S. pneumoniae colonisation with H. influenzae and between H. influenzae colonisation with 
M. catarrhalis. Meanwhile, negative interactions between colonisation by S. aureus with S. 
pneumoniae and M. catarrhalis have also been described. Moreover, among HIV-infected 
children S. aureus was also negatively associated with both S. pneumoniae and H. influenzae, 
while among HIV-infected and HIV-uninfected children S. pneumoniae and H. influenzae 
were both positively associated. 
Cross-sectional methods used in longitudinal studies, for instance binning time into intervals, 
for calculations of odds ratios or interaction should be complemented by methods capable of 
controlling for a third variable for example other organisms interactions. Markov transition 
models seem ideal for investigating acquisition and clearance states and allow for the 
estimations for probability of change of states. 
























Supplement Table 1: Detailed search results 
 Search term Date Database Results (number of 
papers) 
1 Upper respiratory tract December 2018 PubMed 651 
2 Lower respiratory tract December 2018 PubMed 866 
3 Nasopharyngeal colonisation December 2018 PubMed 1 479 
4 Children December 2018 PubMed 2 347 203 
5 1 or 2 or 3 December 2018 PubMed 2 525 
6 4 and 5 December 2018 PubMed 945 
7 Streptococcus pneumoniae December 2018 PubMed 33 089 
8 Staphylococcus aureus December 2018 PubMed 113 235 
9 Haemophilus influenzae December 2018 PubMed 21 569 
10 Moraxella catarrhalis December 2018 PubMed 3 343 
11 7 or 8 or 9 or 10 December 2018 PubMed 156 097 
12 6 and 11 December 2018 PubMed 706 
13 Interactions December 2018 PubMed 751 675 
14 Colonisation December 2018 PubMed 54 575 
15 Carriage December 2018 PubMed 13 940 
16 13 or 14 or 15 December 2018 PubMed 812 618 
17 12 and 16 December 2018 PubMed 706 
18 Pneumonia December 2018 PubMed 145 070 
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Abstract 
Background In the aetiology of bacterial pneumonia it is generally accepted that infection is 
preceded by nasopharyngeal (NP) colonisation. Several studies have shown that NP flora 
develop and establish in first year of life or early in childhood. Temporal organism 
interactions have rarely been explored due to the need for longitudinal data and the 
complexity of the statistical models for recurrent events.  
Methods We sought to identify, describe, and quantify the temporal interactions existing 
between selected key bacteria colonising the nasopharynx in infants (up to 1 year of life). We 
then compared patterns in those children who go on to develop pneumonia versus those who 
do not. We applied multi-state models to examine the patterns of transition among states of 
colonisation while accounting for key confounders.  
Results There were 760 individuals included in the analysis, with a total of 16,346 NP 
samples available and a median 364 person-days (IQR 346 – 365 person-days). There were 
temporally sustained positive interactions between Streptococcus pneumoniae with 
Haemophilus influenzae; Streptococcus pneumoniae with Moraxella catarrhalis; and 
Haemophilus influenzae with Moraxella catarrhalis. Moreover, the extent of association 
generally decreased with child age. Staphylococcus aureus had consistent negative 
interactions with other organisms.  
Conclusions We have developed a flexible framework that characterised interactions 
between organisms while accounting for key time-varying confounders. We have 
demonstrated that multi-state models provide a useful approach to supplement classical 





In the aetiology of bacterial pneumonia it is generally accepted that infection is preceded by 
nasopharyngeal (NP) colonisation [1]. Several studies have shown that NP bacterial flora 
develop and establish in the first year of life or early in childhood. Of the pathogens that 
colonise the nasopharynx the most commonly studied are Streptococcus pneumoniae, 
Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus, in part because 
they are known contributors to lower respiratory tract infections [2].  
Colonisation of the nasopharynx of young children is often asymptomatic [3], and concurrent 
with complex organism interactions. Colonisation is impacted upon by different risk factors 
such as antimicrobial treatment and/or vaccination [2], as well as environmental exposures, 
which may act as mediators.  
A body of literature exists on organism interactions [1, 3-7].Temporal organism interactions 
have however not been explored in depth, especially regarding whether observed colonisation 
patterns are resultant of the host’s immunity, synergism or antagonism between bacterial 
species interactions. An understanding of underlying temporal organism interactions in the 
nasopharynx may help predict how novel vaccines against these bacterial species may 
influence the ecology in this niche area. 
We sought to identify, describe, and quantify temporal interactions existing between selected 
key bacteria present in the nasopharynx in infants (up to 1 year of life), and to compare these 
patterns in children who go on to develop pneumonia versus those who do not. We also 
explored methods for estimation of temporal interactions. We investigated patterns of 
carriage and co-carriage in a cohort of South African children residing in a peri-urban area 
near Cape Town, South Africa. We describe multivariable marginal models and multi-state 
models appropriate for the analysis of longitudinal data.  
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Participants and Methods 
Study design 
Data from the Drakenstein Child Health Study (DCHS) [15, 16] are used. DCHS is a 
population-based birth cohort study investigating early-life determinants of child health in a 
peri-urban setting in the Western Cape province of South Africa. The cohort includes more 
than 1000 mother-infant pairs engaged with the public sector health services from antenatal 
care until at least five years of age. Follow-up is ongoing- all infants have completed at least 
two years of follow up.   
For this study, data come from nasopharyngeal (NP) swab samples taken every two weeks for 
the first year of life in a subset of more than 800 infants whose mothers enrolled in monitored 
particular cohort of the DCHS. In addition to routine mother-infant visits, study personnel 
actively surveyed episodes of illness, including lower respiratory tract infections (LRTI).  
Data collection method 
NP swabs were taken every two weeks and at LRTI episodes. Collected NP swabs (Copan 
flocked swab, FLOQSwabsTM, COPAN Diagnostics, Murrieta, CA, United States) were 
immediately placed into 1ml skim milk-tryptone-glucose-glycerol (STGG), transported at 4 
°C to the laboratory within 2 hours of collection and frozen at −80 °C for later batch culture. 
Swabs were inoculated onto Mannitol Salt Agar (MSA) at the National Health Laboratory 
Services, Green Point Media Laboratory Cape Town, South Africa and incubated at 35 °C for 
18–24 hours prior to measurement. The presence or absence of four organisms: Streptococcus 
pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus was 
recorded. Demographic and other data were collected by trained study personnel using 




Clinical and demographic parameters included sex of the child, date of birth, HIV status of 
mother and infant, and residential location. If an episode of lower respiratory tract infection 
occurred in the first year of life these data were recorded. Age groupings were used to stratify 
results for descriptive purposes and these included: birth-4 weeks, 5-12 weeks, 13-24 
weeks and 25-52 weeks. These age categories were selected as they represent common stages 
in infant grown. All intervals are inclusive.  
Carriage was defined on a per-sample and per-individual basis. Individuals were defined with 
positive carriage if they had any positive sample in the follow-up period. The frequency 
(percentage) of positive samples/individuals was calculated taking as the denominator the 
total samples available overall or in the specified time period. Co-carriage required the same 
sample to be a positive sample for both specified organisms.  
Statistical analysis 
Total person-days were calculated as the age (in days) at the last available sample for 
each individual. Age (in days) at the first positive sample was used to determine the age 
of first carriage. The cumulative time spent positive for carriage/colonisation was 
calculated as the sum of the intervals between consecutive positive samples (for each 
organism) including the following interval up to the first negative sample. Time regarded as 
negative was taken to be the individual total person-days minus the cumulative time regarded 
as positive.  
Temporal pairs are defined as a pair of consecutive samples from the same individual. 
Clearance events are defined in a temporal pair, where the first sample is +ve (carriage) for a 
given organism and the second sample is –ve (no carriage). Acquisition events are the reverse 
(-ve → +ve). Steady state events are those remaining in a positive carriage state (+ve → +ve) 
or those remaining in a non-carriage state (-ve → -ve) over the temporal pair.  
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Generalised mixed effects models using a logit link were used to estimate the time varying
association of organism carriage with the development of pneumonia, while enabling 
adjustment by key confounders. Crude and age-adjusted odds ratio (OR) and 95% 
confidence intervals were estimated for the positive-positive temporal interaction versus no 
association or positive-negative interaction. 
Kaplan-Meier estimates were used to reflect time to first carriage. Markov multi state models 
(MSMs) were used to describe how organism acquisition in infancy rolls out with age and 
associated probabilities of clearance, new acquisition or persistent carriage. We fitted 
piecewise constant MSMs with knots fit at 28days (d), 84d, 168d and 365d corresponding to 
the a priori defined age categories. All MSMs were adjusted for age at sample collection and 
the allowable state-transitions are described in Supplement Figure 1. Observed versus 
expected prevalence plots were used to graphically assess model fit. Estimated transition 
probabilities were summarised numerically and graphically.   
Ethical approval 
All study procedures were carried out under approval by the University of Cape Town 
Human Research Ethics Committee for the DCHS study (HREC: 401/2009) and for this 
analysis (HREC: 240/2018). Participants in the original study provided written consent at 
recruitment and consent was updated annually if maternal participants wished to remain in 
the study.  
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Results 
There were 760 individuals included in the analysis, with a total of 16,346 NP samples 
available and a median 364 person-days (IQR 346 – 365 person-days). S. pneumoniae was 
predominant, found in >55% of all samples and demonstrating carriage in >95% of 
individuals at least once by 12 months of age (Figures 1 and 2, Supplementary Table 1). H. 
influenzae and M. catarrhalis had 35% and 41% positive carriage respectively in all samples, 
and appeared at least once in >90% of individuals. S. aureus was less common (25% of 
samples and 88% of individuals) and also had a strikingly different pattern of first acquisition 
compared to the other three organisms (Figures 1 and 2), demonstrating a rapid increase in 
carriage prevalence until approximately 4 weeks and subsequently declining. S. aureus 
carriage appeared earlier than other bacterial species (Figure 2; Table 1) with first carriage 
event occurring at a median 28 days of age (IQR: 15 – 58 days) as compared to H. influenzae 
where first carriage occurred at a median 97 days of age (IQR: 57 – 155 days). Individuals 
remained positive for S. aureus for the shortest cumulative time, accruing a median 121 days 
(IQR: 55 – 180 days) and median 36% of the total person-days while both H. influenzae and 
S. pneumoniae had positive carriage for >200 days on average (Table 1).




Figure 2. Cumulative probability of first carriage of bacterial organism by time (age in days). 
Table 1. Statistical summary of estimated time spent with organism carriage (sum of person-
days between consecutive positive samples for each individual) and the time spent without 


















S. aureus 28 (15, 68) 121 (55, 180) 35.9% (16.0, 54.0) 219 (152, 286) 364 (346, 365) 
S. pneumoniae 69 (41, 104) 246 (168, 301) 73.2% (52.9, 86.5) 88 (45, 156) 364 (346, 365) 
H. influenzae 97 (57, 155) 168 (86, 238) 49.7% (26.7, 68.7) 169 (99, 239) 364 (346, 365) 
M. catarrhalis 73 (43, 112) 200 (140, 264) 60.8% (43.9, 74.5) 127 (84, 193) 364 (346, 365) 
# among those ever positive; ^ Calculated as the median (IQR) of the individual sum of person-days between 
consecutive colonized samples including the right hand period (up to the first non-colonised sample). *Calculated 
as the median (IQR) of the individual person-days minus the individual days spent colonised 
 
 
S. pneumoniae had the highest co-carriage prevalence with H. influenzae and M. catarrhalis 
(both 25%) but this varied by age category (Table 2). H. influenzae also co-occurred 
frequently with M. catarrhalis (19%). In contrast, S. aureus co-carriage was least prevalent 
with S. pneumoniae (12%), H. influenzae (5%) or M. catarrhalis (6%). Co-carriage 
frequencies differed considerably by age category, at least partially reflecting the relative 
prevalence of carriage by age. The co-carriage frequency of H. influenzae and M. catarrhalis; 
H. influenzae and S. pneumoniae; and S. pneumoniae and M. catarrhalis, increased with age, 
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from a rate of 4-6% in the first four weeks of life to 26-34% in the second 6 months of life. 
Co-carriage of S. aureus with all other organisms peaked between 5 and 12 weeks of age. 
Carriage and co-carriage rates were similar among those children who experienced LRTI 
compared to those who did not (Table 2). Seasonal carriage varied (Supplementary Figure 2), 
but to a lesser extent as compared to variance by age.   
Overall, M. catarrhalis demonstrated the most stochastic or short term carriage over time, 
with 16% of temporal pairs representing clearance (carriage → absent) and 18% of temporal 
pairs being acquisition events (absent → carriage). This contrasts with S. aureus which had 
clearance events occurring in only 10% of temporal pairs and a similar rate for acquisition 
events (Supplementary Table 2).   
S. aureus was negatively associated with all three bacterial species S. pneumoniae OR (95% 
CI): 0.68 (0.63 – 0.73), H. influenzae 0.41 (0.38 – 0.45) and M. catarrhalis 0.41 (0.38 – 0.45) 
in NP samples. Positive association interactions were evident between S. pneumoniae and H. 
influenzae OR (95% CI): 3.18 (2.97 – 3.41) and S. pneumoniae and M. catarrhalis 2.18 (2.04 
– 2.32). H. influenzae and M. catarrhalis were also positively associated OR (95% CI): 2.58 








Table 2. Percentage (count) of samples co-occurring by age category and LRTI status 
Among all children 
Age 
category 
N SA + SP SA + HI SA + MC SP + HI SP + MC HI + MC 
Birth – 4 
weeks 
3019 10.2% (307) 3.88% (117) 5.3% (160) 5.17% (156) 6.36% (192) 4.21% (127) 
5 – 12 
weeks 
2768 20.7% (572) 8.24% (228) 11.1% (307) 20.1% (557) 22% (609) 15% (416) 
13 – 24 
weeks 
4416 14.4% (634) 6.5% (287) 6.75% (298) 30.8% (1361) 32.1% (1417) 23.2% (1024) 
25-52 
weeks 
6143 6.85% (421) 3.48% (214) 4.49% (276) 33.7% (2068) 35.6% (2186) 26% (1598) 
Birth – 1 
year 
(overall) 
16346 11.8% (1934) 5.18% (846) 6.37% (1041) 25.3% (4142) 26.9% (4404) 19.4% (3165) 





SA + SP SA + HI SA + MC SP + HI SP + MC HI + MC 
Birth – 4 
weeks 
1379 9.2% (127) 3.7% (51) 5.1% (70) 5.3% (73) 7.2% (100) 4.1% (56) 
5 – 12 
weeks 
1307 20.6% (270) 7.5% (98) 10.9% (142) 17.8% (233) 21.3% (279) 15.1% (197) 
13 – 24 
weeks 
2051 15.6% (319) 7.3% (149) 7.6% (155) 28.8% (590) 31.7% (650) 23.2% (476) 
25-52 
weeks 
2838 7.3% (208) 3.3% (93) 4.3% (123) 32.7% (927) 36.2% (1026) 26.0% (738) 
Birth – 1 
year 
(overall) 
7575 12.2% (924) 5.2% (391) 6.5% (490) 24.1% (1823) 27.1% (2055) 19.4% (1467) 





SA + SP SA + HI SA + MC SP + HI SP + MC HI + MC 
Birth – 4 
weeks 
1640 11.0% (180) 4.0% (66) 5.5% (90) 5.1% (83) 5.6% (92) 4.3% (71) 
5 – 12 
weeks 
1461 20.7% (302) 8.9% (130) 11.3% (165) 22.2% (324) 22.6% (330) 15.0% (219) 
13 – 24 
weeks 
2365 13.3% (315) 5.8% (138) 6.0% (143) 32.6% (771) 32.4% (767) 23.2% (548) 
25-52 
weeks 
3305 6.4% (213) 3.7% (121) 4.6% (153) 34.5% (1141) 35.1% (1160) 26.0% (860) 
Birth – 1 
year 
(overall) 
8771 11.5% (1010) 5.2% (455) 6.3% (551) 26.4% (2319) 26.8% (2349) 19.4% (1698) 





Mixed effects models adjusting for sex, site, season of birth, and age found temporally 
sustained positive associations between the co-carriages of S. pneumoniae with both H. 
influenzae, and M. catarrhalis, but no association with S. aureus. Moreover the extent 
generally decreased with infant’s age (Table 3). Models including an indicator variable for 
LRTI in the first year of life had similar associations between organisms, and no evidence of 
meaningful associations with LRTI (Table 3).  
Table 3. Associations with S. pneumoniae by generalised mixed effects models with a logit link 
and random effect term for individual. Each organism represents an independent model.  
Models without LRTI status Main effects models^ Age interaction models^ 
 Est (SE) P-value Est (SE) P-value 
S. aureus 0.024 (0.05) 0.617 0.021 (0.05) 0.683 
S. aureus * age interaction - - -0.008 (0.05) 0.874 
H. influenza 0.73 (0.04) < 0.0001 0.86 (0.04) < 0.0001 
H. influenza * age interaction - - -0.55 (005) < 0.0001 
M. catarrhalis 0.52 (0.04) < 0.0001 0.54 (0.04) < 0.0001 
M. catarrhalis * age interaction - - -0.51 (0.04) < 0.0001 
Models including LRTI status 
S. aureus 0.024 (0.05) 0.619 0.28 (0.07) < 0.0001 
S. aureus * age interaction - - -0.009 (0.05) 0.864 
LRTI in the first year of life 0.13 (0.10) 0.279 0.13 (0.12) 0.269 
H. influenza 0.73 (0.04) < 0.0001 0.79 (0.04) < 0.0001 
H. influenza * age interaction - - -0.55 (0.04) < 0.0001 
LRTI in the first year of life -0.01 (0.12) 0.934 -0.043 (0.12) 0.721 
M. catarrhalis 0.52 (0.04) < 0.0001 0.54 (0.04) < 0.0001 
M. catarrhalis * age interaction - - -0.51 (0.04) < 0.0001 
LRTI in the first year of life 0.12 (0.12) 0.319 0.09 (0.12) 0.456 
^ Adjusted for sex, site, season of birth, scaled age at collection, main effect for age retained in model and statistically 
significant for all models (p < 0.0001);  
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Multi-state models were built to estimate transition probabilities between co-carriage states, 
as well as estimate the association between predefined risk factors and transition between 
states. The general multi-state model scheme can be found in Supplement Figure 1. The 
model allowed for four possible states: no carriage, carriage with two organisms, or carriage 
with one organism and negative for the other. The multi-state process was assumed to be 
Markovian, with transition intensities modelled as piecewise constant.  
The probability of acquisition of S. pneumoniae is modified by earlier carriage of H. 
influenzae or M. catarrhalis, however the reverse is not true. Positive H. influenzae carriage 
increases the probability of acquisition of S. pneumoniae with transition probabilities from 
0.15 (95% CI 0.14-0.17) to 0.36 (95% CI 0.17, 0.54) for age categories over 28 days (Table 
4), compared to the probability of acquisition of S. pneumoniae alone at 0.015 (95% CI 
0.043-0.076) to 0.088 (95% CI 0.075-0.10) over the same age categories. This is in contrast 
to the probability of H. influenzae acquisition, which is similar with and without prior S. 
pneumoniae carriage. Similarly, carriage of M. catarrhalis increases the risk of S. 
pneumoniae acquisition (probability 0.24 vs 0.14 between 84 -168d of age), but S. 
pneumoniae carriage does little to modify the risk of M. catarrhalis acquisition. There was no 
evidence of differences between the acquisition of S. pneumoniae or S. aureus with relation 
to co-carriage.  
There is no difference in the clearance of S. pneumoniae related to H. influenzae carriage, yet 
clearance of H. influenzae before 6 months of age is far less likely if coming from a state of 
co-carriage (probability between 0.04 - 0.07) compared to sole carriage (probability 0.23 - 
0.12). The only evidence of differences in clearance probability in the models investigating S. 
pneumoniae and M. catarrhalis are in the probability of M. catarrhalis clearance before 28 
days, which is 0.24 (95% CI 0.15 - 0.38) if carried alone and only 0.058 (55% CI 0.01 - 0.30) 
if carried with S. pneumoniae, though these confidence intervals overlap. Multi-state models 
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incorporating LRTI as a fifth absorbing state did not converge, nor did the secondary analysis 
of presented models on data subsets by LRTI status. Diagnostics for the presented models 
were accurate based on visual inspection of the predicted vs observed probability plots.  
Table 4A. Predicted transition probabilities (95% confidence intervals) for the probability of 
state changes in each time period estimated with pairwise multistate models including S. 
pneumoniae, adjusted for sex, site, season of birth. 
 
Predicted probability (95% CI) of transition in the next 14 days with covariates at their 
means 
S. pneumoniae with H. influenzae 0-28d 28-84d 84-168d 365d + 
Acquisition events 
Gain SP (from negative SP/HI) 0.019 (0.01, 0.034) 0.051 (0.043, 0.076) 0.066 (0.054, 0.080) 0.088 (0.075, 0.10) 
Gain SP (from positive HI only) 0.062 (0.00, 0.13) 0.15 (0.14, 0.17) 0.21 (0.19, 0.22) 0.36 (0.17, 0.54) 
Gain HI  (from negative SP/HI) 0.067 (0.052, 0.086) 0.11 (0.098, 0.18) 0.13 (0.12, 0.15) 0.15 (0.13, 0.16) 
Gain HI (from positive SP only) 0.011 (0.00, 0.35) 0.13 (0.095, 0.32) 0.19 (0.15, 0.22) 0.21 (0.19, 0.22) 
Gain both (from negative SP/HI) 0.017 (0.00, 0.030) 0.013 (0.011, 0.78) 0.036 (0.029, 0.057) 0.050 (0.043, 0.069) 
Clearance events 
Lose SP (from SP positive only) 0.37 (0.18, 0.63) 0.20 (0.00, 0.24) 0.19 (0.16, 0.23) 0.19 (0.17, 0.22) 
Lose SP (from positive both) 0.35 (0.061, 0.66) 0.17 (0.13, 0.22) 0.15 (0.13, 0.17) 0.20 (0.18, 0.21) 
Lose HI (from HI positive only) 0.23 (0.15, 0.38) 0.12 (0.00, 0.14) 0.087 (0.075, 0.10) 0.086 (0.076, 0.097) 
Lose HI (from positive both) 0.044 (0.00, 0.57) 0.065 (0.043, 0.095) 0.063 (0.051, 0.078) 0.068 (0.060, 0.076) 
Lose both 0.088 (0.048, 0.90) 0.051 (0.00, 0.089) 0.039 (0.030, 0.056) 0.043 (0.037, 0.053) 
S. pneumoniae with M. catarrhalis 0-28d 28-84d 84-168d 168+ 
Acquisition events 
Gain SP (from negative SP/MC) 0.066 (0.051, 0.081) 0.088 (0.059, 0.10) 0.14 (0.12, 0.16) 0.16 (0.14, 0.18) 
Gain SP (from positive MC only) 0.081 (0.00, 0.16) 0.18 (0.082, 0.28) 0.24 (0.15, 0.27) 0.31 (0.24, 0.33) 
Gain MC  (from negative SP/MC) 0.065 (0.052, 0.084) 0.10 (0.089, 0.29) 0.12 (0.11, 0.15) 0.12 (0.11, 0.15) 
Gain MC (from positive SP only) 0.13 (0.01, 0.19) 0.10 (0.048,0.34) 0.14 (0.092, 0.17) 0.15 (0.12, 0.18) 
Gain both (from negative SP/MC) 0.011 (0.00, 0.067) 0.020 (0.014, 0.69) 0.042 (0.033 ,0.096) 0.064 (0.050, 0.20) 
Clearance events 
Lose SP (from SP positive only) 0.28 (0.17, 0.46) 0.26 (0.00, 0.33) 0.21 (0.18, 0.27) 0.19 (0.16, 0.23) 
Lose SP (from positive both) 0.25 (0.074, 0.42) 0.26 (0.17, 0.32) 0.26 (0.20, 0.30) 0.29 (0.24, 0.31) 
Lose MC (from MC positive only) 0.24 (0.15, 0.38) 0.099 (0.00, 0.20) 0.082 (0.070, 0.17) 0.090 (0.076, 0.17) 
Lose MC (from positive both) 0.058 (0.01, 0.30) 0.068 (0.045, 0.097) 0.060 (0.049, 0.090) 0.063 (0.056, 0.090) 




Table 4B. Predicted transition probabilities (95% confidence intervals) for the probability of 
state changes in each time period estimated with pairwise multistate models including S. 
pneumoniae and S aureus, adjusted for sex, site, season of birth. 
S. pneumoniae with S aureus 0-28d 28-84d 84+ d 
Acquisition events 
Gain SP (from negative SP/SA) 0.22 (0.19, 0.25) 0.092 (0.077, 0.11) 0.059 (0.053, 0.067) 
Gain SP (from positive SA only) 0.15 (0.00, 0.24) 0.12 (0.10, 0.16) 0.052 (0.00, 0.063) 
Gain SA  (from negative SP/SA) 0.057 (0.043, 0.074) 0.11 (0.091, 0.13) 0.19 (0.18, 0.21) 
Gain SA (from positive SP only) 0.090 (0.00, 0.12) 0.11 (0.093, 0.14) 0.13 (0.00,0.16) 
Gain both(from negative SP/SA) 0.020 (0.00, 0.073) 0.016 (0.013, 0.13) 0.013 (0.00, 0.17) 
Clearance events 
Lose SP (from SP positive only) 0.097 (0.073, 0.21) 0.12 (0.099,0.14) 0.20 (0.17, 0.34) 
Lose SP (from positive both) 0.063 (0.024, 0.19) 0.14 (0.11, 0.17) 0.29 (0.19, 0.31) 
Lose SA (from SA positive only) 0.14 (0.070, 0.39) 0.11 (0.085,0.14) 0.097 (0.085, 0.15) 
Lose SA (from positive both) 0.23 (0.15, 0.42) 0.081 (0.061,0.11) 0.077 (0.059, 0.090) 
Lose both 0.028 (0.017, 0.74) 0.039 (0.024, 0.094) 0.031 (0.028, 0.74) 
 
Discussion 
Statistical modelling of temporal interactions may identify important organism level 
associations that change over time or vary in subgroups of children. We found positive and 
sustained interactions between S. pneumonia and both H. influenzae and M. catarrhalis, 
where our models indicated that preceding carriage or colonisation with either H. influenzae 
or M. catarrhalis may increase the risk of colonisation with S. pneumonia.   
Timing of carriage and overall prevalence of carriage are in line with other findings in similar 
populations [1-7] with overall high exposure to S. pneumonia, H. influenza and M. 
catarrhalis during the first year of life and rapid and early exposure to S. aureus. Co-carriage 
is common, occurring in 5% - 26% of all samples, depending on the age of the children and 
the specific organisms. Similarly, clearance and acquisition events made up approximately 
20% of all transitions suggesting that patterns of acquisition and clearance are dynamic. 
Carriage, co-carriage and transition frequency did not vary appreciably when comparing 
children who experienced LRTI in the first year of life versus those who had no lower tract 
respiratory infections. This suggests that the underlying pattern of exposure may be similar in 
58 
those children who do not experience LRTI in the first year of life, and so further 
investigation into the timing of exposure in the period before LRTI onset is critical.  
The predicted transition probabilities from the multi-state models showed evidence of 
changing temporal risk of acquisition and clearance of S. pneumonia depending on co-
carriage with other organisms.  
This study has several strengths including an unprecedented sample frame of repeated NP 
samples in over 700 children during the first year of life and which accounted for children 
who experienced or did not experience lower respiratory tract infections (LRTIs). This 
represented a rare opportunity to carefully identify and analyse temporal interactions between 
organisms.  
As an observational cohort, the positive associations that we found do not necessarily 
represent causal effects, and even though the temporal order was accounted for, organism 
carriage is not the same as colonisation or infection. Treatment with antibiotics and the 
impact of vaccination have not been accounted for here, and findings may change when 
considering colonisation with organisms rather than simple carriage, as well as adjustment for 
known environmental and clinical risk factors. The cohort is situated in a specific context
and setting of South Africa, and so the results found here may not be generalizable to 
other settings.  
We have presented an initial investigation into temporal interactions in a densely sampled 
longitudinal data set.  Further analyses might consider different definitions of carriage, to get 
closer to the idea of colonisation, and account for washout periods due to antibiotics and/or 
other treatments. The multi-state models applied here have demonstrated their use as an 
important statistical tool in understanding longitudinal data and change between states 
over time.   
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Conclusion 
Application of multi-state models to the temporal changes in nasopharyngeal carriage of four 
key disease-causing bacteria, has provided insights into the organism interactions occurring 
in the host. This work demonstrates that multi-state models are a useful additional statistical 
tool in cases where there are sufficient frequencies of longitudinal measures and repeat 
events.  
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Manuscript supplement  
Supplement Table 1: Percentage (frequency) of samples and individuals with organism carriage in age 
groups at the time of collection. Individuals were considered positive if they had any positive sample 
collected during the relevant age category.  
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Among children who experienced LRTI 
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Among children who never experienced LRTI 
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Supplement Table 2. Percentage (frequency) of each pair of sequential samples (n = 15,608 
pairs) that had a clearance, acquisition or remained in existing state from observation t to 
observation t+1. 
 S. aureus S. pneumoniae H. influenzae M. catarrhalis 
Clearance  











































   
 
Supplement Figure 1. Schematic of two-organism states and transitions. Some organism 











Supplement Figure 3.  Mosaic plot of co-colonisation transition matrix for S. pneumonia 
with other organisms. Rows represent origin state (time t), columns represent next state (time 
t+1) and size reflects probability of transition.  
Supplement Figure 4.  Selected model diagnostics for multi-state models baseline (a) and covariate 
adjusted (b) for the S. pneumonia and M. catarrhalis model.
(a) (b)
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For non-commercial purposes, lets others distribute and copy the 
article, and to include in a collective work (such as an anthology), as 
long as they credit the author(s) and provided they do not alter or 
modify the article.  
The gold open access publication fee for this journal is USD 3000, 
excluding taxes. Learn more about Elsevier's pricing policy: 
https://www.elsevier.com/openaccesspricing.  
Green open access  
Authors can share their research in a variety of different ways and 
Elsevier has a number of green open access options available. We 
recommend authors see our open access page for further 
information. Authors can also self-archive their manuscripts 
immediately and enable public access from their institution's 
repository after an embargo period. This is the version that has 
been accepted for publication and which typically includes author-
incorporated changes suggested during submission, peer review and 
in editor-author communications. Embargo period: For subscription 
articles, an appropriate amount of time is needed for journals to 
deliver value to subscribing customers before an article becomes 
freely available to the public. This is the embargo period and it 
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begins from the date the article is formally published online in its 
final and fully citable form. Find out more.  
This journal has an embargo period of 12 months.  
Elsevier Researcher Academy  
Researcher Academy is a free e-learning platform designed to 
support early and mid-career researchers throughout their research 
journey. The "Learn" environment at Researcher Academy offers 
several interactive modules, webinars, downloadable guides and 
resources to guide you through the process of writing for research 
and going through peer review. Feel free to use these free resources 
to improve your submission and navigate the publication process 
with ease.  
Language (usage and editing services)  
Please write your text in good English (American or British usage is 
accepted, but not a mixture of these). Authors who feel their English 
language manuscript may require editing to eliminate possible 
grammatical or spelling errors and to conform to correct scientific 
English may wish to use the English Language Editing service 
available from Elsevier's Author Services.  
Informed consent and patient details  
Studies on patients or volunteers require ethics committee approval 
and informed consent, which should be documented in the paper. 
Appropriate consents, permissions and releases must be obtained 
where an author wishes to include case details or other personal 
information or images of patients and any other individuals in an 
Elsevier publication. Written consents must be retained by the 
author but copies should not be provided to the journal. Only if 
specifically requested by the journal in exceptional circumstances 
(for example if a legal issue arises) the author must provide copies 
of the consents or evidence that such consents have been obtained. 
For more information, please review the Elsevier Policy on the Use 
of Images or Personal Information of Patients or other Individuals. 
Unless you have written permission from the patient (or, where 
applicable, the next of kin), the personal details of any patient 
included in any part of the article and in any supplementary 
materials (including all illustrations and videos) must be removed 
before submission.  
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Submission  
Our online submission system guides you stepwise through the 
process of entering your article details and uploading your files. The 
system converts your article files to a single PDF file used in the 
peer-review process. Editable files (e.g., Word, LaTeX) are required 
to typeset your article for final publication. All correspondence, 
including notification of the Editor's decision and requests for 
revision, is sent by e-mail.  
Submit your article  
Please submit your article via 
https://www.evise.com/profile/api/navigate/AEP.  
Referees  
Please submit the names and institutional e-mail addresses of 
several potential referees. For more details, visit our Support site. 
Note that the editor retains the sole right to decide whether or not 
the suggested reviewers are used.  




Manuscript Order  
A cover letter should accompany the manuscript, addressing conflict 
of interest, authorship and nonduplication criteria. Please include 
suggestions of possible peer reviewers, as well. Submit entire 
manuscript on line in the following order: (1) title page; (2) 
abstract; (3) list of abbreviations and acronyms; (4) text; (5) 
acknowledgments and funding; (6) references; (7) legends; (8) 
tables; (9) figures. Number all pages in sequence, beginning with 
the title page as 1, abstract as 2, etc. In a cover letter indicate the 
single category the manuscript fits best.  
Desk Rejections  
When a manuscript is received, a initial triage is conducted by the 
Editor-in-Chief and Managing Editor to identify manuscripts that fit 
the journal's scope. In some cases, manuscripts may also be 
reviewed at this stage by an Associate Editor with subject matter 
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expertise in the area addressed by the manuscript. For details on 
why submissions are commonly rejected at this stage, please view 
our Desk Rejection Statement.  
PREPARATION  
NEW SUBMISSIONS  
Submission to this journal proceeds totally online and you will be 
guided stepwise through the creation and uploading of your files. 
The system automatically converts your files to a single PDF file, 
which is used in the peer-review process. As part of the Your Paper 
Your Way service, you may choose to submit your manuscript as a 
single file to be used in the refereeing process. This can be a PDF 
file or a Word document, in any format or lay- out that can be used 
by referees to evaluate your manuscript. It should contain high 
enough quality figures for refereeing. If you prefer to do so, you 
may still provide all or some of the source files at the initial 
submission. Please note that individual figure files larger than 10 MB 
must be uploaded separately.  
References  
There are no strict requirements on reference formatting at 
submission. References can be in any style or format as long as the 
style is consistent. Where applicable, author(s) name(s), journal 
title/ book title, chapter title/article title, year of publication, volume 
number/book chapter and the article number or pagination must be 
present. Use of DOI is highly encouraged. The reference style used 
by the journal will be applied to the accepted article by Elsevier at 
the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct.  
Formatting requirements  
There are no strict formatting requirements but all manuscripts 
must contain the essential elements needed to convey your 
manuscript, for example Abstract, Keywords, Introduction, Materials 
and Methods, Results, Conclusions, Artwork and Tables with 
Captions. If your article includes any Videos and/or other 
Supplementary material, this should be included in your initial 
submission for peer review purposes.  
Divide the article into clearly defined sections.  
 82 
Figures and tables embedded in text  
Please ensure the figures and the tables included in the single file 
are placed next to the relevant text in the manuscript, rather than 
at the bottom or the top of the file. The corresponding caption 
should be placed directly below the figure or table.  
Peer review  
This journal operates a single blind review process. All contributions 
will be initially assessed by the editor for suitability for the journal. 
Papers deemed suitable are then typically sent to a minimum of two 
independent expert reviewers to assess the scientific quality of the 
paper. The Editor is responsible for the final decision regarding 
acceptance or rejection of articles. The Editor's decision is final. 
More information on types of peer review.  
REVISED SUBMISSIONS  
Use of word processing software  
Regardless of the file format of the original submission, at revision 
you must provide us with an editable file of the entire article. Keep 
the layout of the text as simple as possible. Most formatting codes 
will be removed and replaced on processing the article. The 
electronic text should be prepared in a way very similar to that of 
conventional manuscripts (see also the Guide to Publishing with 
Elsevier). See also the section on Electronic artwork.  




To avoid unnecessary errors you are strongly advised to use the 
'spell-check' and 'grammar-check' functions of your word processor.  
Article structure  
Subdivision - unnumbered sections  
Divide your article into clearly defined sections. Each subsection is 
given a brief heading. Each heading should appear on its own 
separate line. Subsections should be used as much as possible when 
cross- referencing text: refer to the subsection by heading as 
opposed to simply 'the text'.  
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Introduction  
State the objectives of the work and provide an adequate 
background, avoiding a detailed literature survey or a summary of 
the results.  
Material and methods  
Provide sufficient details to allow the work to be reproduced by an 
independent researcher. Methods that are already published should 
be summarized, and indicated by a reference. If quoting directly 
from a previously published method, use quotation marks and also 
cite the source. Any modifications to existing methods should also 
be described.  
Results  
Results should be clear and concise.  
Discussion  
This should explore the significance of the results of the work, not 
repeat them. A combined Results and Discussion section is often 
appropriate. Avoid extensive citations and discussion of published 
literature.  
Conclusions  
The main conclusions of the study may be presented in a short 
Conclusions section, which may stand alone or form a subsection of 
a Discussion or Results and Discussion section.  
Appendices  
If there is more than one appendix, they should be identified as A, 
B, etc. Formulae and equations in appendices should be given 
separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent 
appendix, Eq. (B.1) and so on. Similarly for tables and figures: 
Table A.1; Fig. A.1, etc.  
Essential title page information  
• Title. Concise and informative. Titles are often used in 
information-retrieval systems. Avoid abbreviations and formulae 
where possible. • Author names and affiliations. Please clearly 
indicate the given name(s) and family name(s) of each author and 
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check that all names are accurately spelled. You can add your name 
between parentheses in your own script behind the English 
transliteration. Present the authors' affiliation addresses (where the 
actual work was done) below the names. Indicate all affiliations with 
a lower- case superscript letter immediately after the author's name 
and in front of the appropriate address. Provide the full postal 
address of each affiliation, including the country name and, if 
available, the e-mail address of each author.  
• Corresponding author. Clearly indicate who will handle 
correspondence at all stages of refereeing and publication, also 
post-publication. This responsibility includes answering any future 
queries about Methodology and Materials. Ensure that the e-mail 
address is given and that contact details are kept up to date 
by the corresponding author.  
• Present/permanent address. If an author has moved since the 
work described in the article was done, or was visiting at the time, a 
'Present address' (or 'Permanent address') may be indicated as a 
footnote to that author's name. The address at which the author 
actually did the work must be retained as the main, affiliation 
address. Superscript Arabic numerals are used for such footnotes.  
Highlights  
Highlights are optional yet highly encouraged for this journal, as 
they increase the discoverability of your article via search engines. 
They consist of a short collection of bullet points that capture the 
novel results of your research as well as new methods that were 
used during the study (if any). Please have a look at the examples 
here: example Highlights.  
Highlights should be submitted in a separate editable file in the 
online submission system. Please use 'Highlights' in the file name 
and include 3 to 5 bullet points (maximum 85 characters, including 
spaces, per bullet point).  





An abstract of 200 or fewer words should contain the following 
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clearly labeled elements: purpose, methods, results, and 
conclusions.  
Keywords  
Below the abstract 3 - 10 MeSH heading key words should be 
provided. Mesh headings may be found at 
http://www.nlm.nih.gov/mesh/meshhome.html . Editorials and 
Letters-to-the-Editor do not require abstracts.  
List of abbreviations  
Please list and define all abbreviations and acronyms used in the 
manuscript.  
Acknowledgements  
Collate acknowledgements in a separate section at the end of the 
article before the references and do not, therefore, include them on 
the title page, as a footnote to the title or otherwise. List here those 
individuals who provided help during the research (e.g., providing 
language help, writing assistance or proof reading the article, etc.).  
Formatting of funding sources  
List funding sources in this standard way to facilitate compliance to 
funder's requirements:  
Funding: This work was supported by the National Institutes of 
Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates 
Foundation, Seattle, WA [grant number zzzz]; and the United States 
Institutes of Peace [grant number aaaa].  
It is not necessary to include detailed descriptions on the program 
or type of grants and awards. When funding is from a block grant or 
other resources available to a university, college, or other research 
institution, submit the name of the institute or organization that 
provided the funding.  
If no funding has been provided for the research, please include the 
following sentence:  
This research did not receive any specific grant from funding 
agencies in the public, commercial, or not-for-profit sectors.  
Footnotes  
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Footnotes should be used sparingly. Number them consecutively 
throughout the article. Many word processors build footnotes into 
the text, and this feature may be used. Should this not be the case, 
indicate the position of footnotes in the text and present the 
footnotes themselves separately at the end of the article.  
Artwork  
Electronic artwork General points • Make sure you use uniform 
lettering and sizing of your original artwork. • Preferred fonts: Arial 
(or Helvetica), Times New Roman (or Times), Symbol, Courier. • 
Number the illustrations according to their sequence in the text. • 
Use a logical naming convention for your artwork files. • Indicate 
per figure if it is a single, 1.5 or 2-column fitting image. • For Word 
submissions only, you may still provide figures and their captions, 
and tables within a single file at the revision stage. • Please note 
that individual figure files larger than 10 MB must be provided in 
separate source files. A detailed guide on electronic artwork is 
available. You are urged to visit this site; some excerpts from 
the detailed information are given here. Formats Regardless of 
the application used, when your electronic artwork is finalized, 
please 'save as' or convert the images to one of the following 
formats (note the resolution requirements for line drawings, 
halftones, and line/halftone combinations given below): EPS (or 
PDF): Vector drawings. Embed the font or save the text as 
'graphics'. TIFF (or JPG): Color or grayscale photographs 
(halftones): always use a minimum of 300 dpi. TIFF (or JPG): 
Bitmapped line drawings: use a minimum of 1000 dpi. TIFF (or 
JPG): Combinations bitmapped line/half-tone (color or grayscale): a 
minimum of 500 dpi is required. Please do not:  
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• Supply files that are optimized for screen use (e.g., GIF, BMP, 
PICT, WPG); the resolution is too low. • Supply files that are too low 
in resolution. • Submit graphics that are disproportionately large for 
the content.  
Color artwork  
Please make sure that artwork files are in an acceptable format 
(TIFF (or JPEG), EPS (or PDF), or MS Office files) and with the 
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correct resolution. If, together with your accepted article, you 
submit usable color figures then Elsevier will ensure, at no 
additional charge, that these figures will appear in color online (e.g., 
ScienceDirect and other sites) regardless of whether or not these 
illustrations are reproduced in color in the printed version. For 
color reproduction in print, you will receive information 
regarding the costs from Elsevier after receipt of your 
accepted article. Please indicate your preference for color: in print 
or online only. Further information on the preparation of electronic 
artwork.  
Figure captions  
Ensure that each illustration has a caption. A caption should 
comprise a brief title (not on the figure itself) and a description of 
the illustration. Keep text in the illustrations themselves to a 
minimum but explain all symbols and abbreviations used.  
Tables  
Please submit tables as editable text and not as images. Tables can 
be placed either next to the relevant text in the article, or on 
separate page(s) at the end. Number tables consecutively in 
accordance with their appearance in the text and place any table 
notes below the table body. Be sparing in the use of tables and 
ensure that the data presented in them do not duplicate results 
described elsewhere in the article. Please avoid using vertical rules 
and shading in table cells.  
References  
Citation in text  
Please ensure that every reference cited in the text is also present 
in the reference list (and vice versa). Any references cited in the 
abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may 
be mentioned in the text. If these references are included in the 
reference list they should follow the standard reference style of the 
journal and should include a substitution of the publication date with 
either 'Unpublished results' or 'Personal communication'. Citation of 
a reference as 'in press' implies that the item has been accepted for 
publication.  
Reference links  
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Increased discoverability of research and high quality peer review 
are ensured by online links to the sources cited. In order to allow us 
to create links to abstracting and indexing services, such as Scopus, 
CrossRef and PubMed, please ensure that data provided in the 
references are correct. Please note that incorrect surnames, 
journal/book titles, publication year and pagination may prevent link 
creation. When copying references, please be careful as they may 
already contain errors. Use of the DOI is highly encouraged.  
A DOI is guaranteed never to change, so you can use it as a 
permanent link to any electronic article. An example of a citation 
using DOI for an article not yet in an issue is: VanDecar J.C., Russo 
R.M., James D.E., Ambeh W.B., Franke M. (2003). Aseismic 
continuation of the Lesser Antilles slab beneath northeastern 
Venezuela. Journal of Geophysical Research, 
https://doi.org/10.1029/2001JB000884. Please note the format of 
such citations should be in the same style as all other references in 
the paper.  
Web references  
As a minimum, the full URL should be given and the date when the 
reference was last accessed. Any further information, if known (DOI, 
author names, dates, reference to a source publication, etc.), should 
also be given. Web references can be listed separately (e.g., after 
the reference list) under a different heading if desired, or can be 
included in the reference list.  
Data references  
This journal encourages you to cite underlying or relevant datasets 
in your manuscript by citing them in your text and including a data 
reference in your Reference List. Data references should include the 
following elements: author name(s), dataset title, data repository, 
version (where available), year, and global persistent identifier. Add 
[dataset] immediately before the reference so we can properly 
identify it as a data reference. The [dataset] identifier will not 
appear in your published article.  
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References in a special issue  
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Please ensure that the words 'this issue' are added to any 
references in the list (and any citations in the text) to other articles 
in the same Special Issue.  
Reference management software  
Most Elsevier journals have their reference template available in 
many of the most popular reference management software 
products. These include all products that support Citation Style 
Language styles, such as Mendeley. Using citation plug-ins from 
these products, authors only need to select the appropriate journal 
template when preparing their article, after which citations and 
bibliographies will be automatically formatted in the journal's style. 
If no template is yet available for this journal, please follow the 
format of the sample references and citations as shown in this 
Guide. If you use reference management software, please ensure 
that you remove all field codes before submitting the electronic 
manuscript. More information on how to remove field codes from 
different reference management software.  
Users of Mendeley Desktop can easily install the reference style for 
this journal by clicking the following 
link: http://open.mendeley.com/use-citation-style/annals-of-
epidemiology When preparing your manuscript, you will then be 
able to select this style using the Mendeley plug- ins for Microsoft 
Word or LibreOffice.  
Reference formatting  
There are no strict requirements on reference formatting at 
submission. References can be in any style or format as long as the 
style is consistent. Where applicable, author(s) name(s), journal 
title/ book title, chapter title/article title, year of publication, volume 
number/book chapter and the article number or pagination must be 
present. Use of DOI is highly encouraged. The reference style used 
by the journal will be applied to the accepted article by Elsevier at 
the proof stage. Note that missing data will be highlighted at proof 
stage for the author to correct. If you do wish to format the 
references yourself they should be arranged according to the 
following examples:  
Reference Style  
Follow the general arrangements as given in the “Uniform 
Requirements for Manuscripts Submitted to a Biomedical Journal”. 
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The journal uses the Vancouver style for references. Number 
references consecutively in the order in which they are first 
mentioned in the text. Cite references in text, tables and figures by 
arabic numerals in brackets (for example: text [2]. text [2, 3]). List 
all authors, but if the number exceeds six, list the first six followed 
by et al. Avoid using "abstracts," "unpublished observations" and 
"personal communications" as references. Papers accepted but not 
yet published may be included by stating the journal and adding "In 
Press." If such references are important to the understanding of the 
submitted manuscript, authors may include an electronic copy of the 
reference with their submission. The author is responsible for the 
accuracy of all references. References should be styled as follows:  
Journals  
[1] Paivio A, Jansen B, Becker LJ. Comparisons through the mind's 
eye. Cognition 1975;37(2):635-47. [2] Yuen AWC. Lamotrigine: a 
review of antiepileptic efficacy. Epilepsia 1994;35(Suppl. 5):S33-6. 
[3] VanDecar JC, Russo RM, James DE, Ambeh WB, Franke M. 
Aseismic continuation of the Lesser Antilles slab beneath 
northeastern Venezuela. J Geophys Res 2003;108:2043. https:// 
doi.org/10.1029/2001JB000884.  
Books  
[4] Strunk Jr W, White EB. The elements of style. 3rd ed. New York: 
MacMillan; 1979 [chapter 4]. [5] College bound seniors. Princeton 
(NJ): College Board Publications; 1979. [6] Chaddock TE. Gastric 
emptying of a nutritionally balanced liquid diet. In: Daniel EE, 
editor. Proceedings of the fourth international symposium on 
gastrointestinal motility. Vancouver (British Columbia, Canada): 
Mitchell Press; 1974, p. 83-92.  
Article or Chapter in an Edited Book  
[7] Adams MJ, Briscoe BE, Sinha SK. Interface friction and energy 
dissipation in soft solid processing applications. In: Dowson D, 
Taylor CM, Childs THC, Godet M, Dalmas G, editors. Dissipative 
processes in tribology. Dowson D, editor. Tirbology series, vol. 27. 
Amsterdam: Elsevier; 1994, p. 223-34.  
Edited Book  
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[8] Letheridge S, Cannon CR, editors. Bilingual education: teaching 
English as a second language. New York: Praeger; 1980.  
Article in Press  
[9] Chassin MR, Kosecoff J, Soloman DH. How coronary angiography 
is used. JAMA, in press.  
Website  
[10] Health Care Financing Administration. 1996 statistics at a 
glance,http://www.hcfa.gov/stats/stathili.htm; 1996 [accessed 
13.03.12].  
Dataset  
[11] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for 
Japanese oak wilt disease and surrounding forest compositions, 
Mendeley Data, v1; 2015.  
Journal abbreviations source  
Journal names should be abbreviated according to the List of Title 
Word Abbreviations.  
Video  
Elsevier accepts video material and animation sequences to support 
and enhance your scientific research. Authors who have video or 
animation files that they wish to submit with their article are 
strongly encouraged to include links to these within the body of the 
article. This can be done in the same way as a figure or table by 
referring to the video or animation content and noting in the body 
text where it should be placed. All submitted files should be properly 
labeled so that they directly relate to the video file's content. . In 
order to ensure that your video or animation material is directly 
usable, please provide the file in one of our recommended file 
formats with a preferred maximum size of 150 MB per file, 1 GB in 
total. Video and animation files supplied will be published online in 
the electronic version of your article in Elsevier Web products, 
including ScienceDirect. Please supply 'stills' with your files: you can 
choose any frame from the video or animation or make a separate 
image. These will be used instead of standard icons and will 
personalize the link to your video data. For more detailed 
instructions please visit our video instruction pages. Note: since 
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video and animation cannot be embedded in the print version of the 
journal, please provide text for both the electronic and the print 
version for the portions of the article that refer to this content.  
Supplementary material  
Supplementary material such as applications, images and sound 
clips, can be published with your article to enhance it. Submitted 
supplementary items are published exactly as they are received 
(Excel or PowerPoint files will appear as such online). Please submit 
your material together with the article and supply a concise, 
descriptive caption for each supplementary file. If you wish to make 
changes to supplementary material during any stage of the process, 
please make sure to provide an updated file. Do not annotate any 
corrections on a previous version. Please switch off the 'Track 
Changes' option in Microsoft Office files as these will appear in the 
published version.  
Research data  
This journal encourages and enables you to share data that 
supports your research publication where appropriate, and enables 
you to interlink the data with your published articles. Research data 
refers to the results of observations or experimentation that validate 
research findings. To facilitate reproducibility and data reuse, this 
journal also encourages you to share your software, code, models, 
algorithms, protocols, methods and other useful materials related to 
the project.  
Below are a number of ways in which you can associate data with 
your article or make a statement about the availability of your data 
when submitting your manuscript. If you are sharing data in one of 
these ways, you are encouraged to cite the data in your manuscript 
and reference list. Please refer to the "References" section for more 
information about data citation. For more information on depositing, 
sharing and using research data and other relevant research 
materials, visit the research data page.  
Data linking  
If you have made your research data available in a data repository, 
you can link your article directly to the dataset. Elsevier collaborates 
with a number of repositories to link articles on ScienceDirect with 
relevant repositories, giving readers access to underlying data that 
gives them a better understanding of the research described.  
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There are different ways to link your datasets to your article. When 
available, you can directly link your dataset to your article by 
providing the relevant information in the submission system. For 
more information, visit the database linking page.  
For supported data repositories a repository banner will 
automatically appear next to your published article on 
ScienceDirect.  
In addition, you can link to relevant data or entities through 
identifiers within the text of your manuscript, using the following 
format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; 
PDB: 1XFN).  
Mendeley Data  
This journal supports Mendeley Data, enabling you to deposit any 
research data (including raw and processed data, video, code, 
software, algorithms, protocols, and methods) associated with your 
manuscript in a free-to-use, open access repository. During the 
submission process, after uploading your manuscript, you will have 
the opportunity to upload your relevant datasets directly to 
Mendeley Data. The datasets will be listed and directly accessible to 
readers next to your published article online.  
For more information, visit the Mendeley Data for journals page.  
Data statement  
To foster transparency, we encourage you to state the availability of 
your data in your submission. This may be a requirement of your 
funding body or institution. If your data is unavailable to access or 
unsuitable to post, you will have the opportunity to indicate why 
during the submission process, for example by stating that the 
research data is confidential. The statement will appear with your 
published article on ScienceDirect. For more information, visit the 
Data Statement page.  
AFTER ACCEPTANCE  
Online proof correction  
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Corresponding authors will receive an e-mail with a link to our 
online proofing system, allowing annotation and correction of proofs 
online. The environment is similar to MS Word: in addition to editing 
text, you can also comment on figures/tables and answer questions 
from the Copy Editor. Web-based proofing provides a faster and less 
error-prone process by allowing you to directly type your 
corrections, eliminating the potential introduction of errors.  
If preferred, you can still choose to annotate and upload your edits 
on the PDF version. All instructions for proofing will be given in the 
e-mail we send to authors, including alternative methods to the 
online version and PDF. We will do everything possible to get your 
article published quickly and accurately. Please use this proof only 
for checking the typesetting, editing, completeness and correctness 
of the text, tables and figures. Significant changes to the article as 
accepted for publication will only be considered at this stage with 
permission from the Editor. It is important to ensure that all 
corrections are sent back to us in one communication. Please check 
carefully before replying, as inclusion of any subsequent corrections 
cannot be guaranteed. Proofreading is solely your responsibility.  
Offprints  
The corresponding author will, at no cost, receive a customized 
Share Link providing 50 days free access to the final published 
version of the article on ScienceDirect. The Share Link can be used 
for sharing the article via any communication channel, including 
email and social media. For an extra charge, paper offprints can be 
ordered via the offprint order form which is sent once the article is 
accepted for publication. Both corresponding and co-authors may 
order offprints at any time via Elsevier's Author Services. 
Corresponding authors who have published their article gold open 
access do not receive a Share Link as their final published version of 
the article is available open access on ScienceDirect and can be 
shared through the article DOI link.  
AUTHOR INQUIRIES  
Visit the Elsevier Support Center to find the answers you need. Here 
you will find everything from Frequently Asked Questions to ways to 
get in touch. You can also check the status of your submitted article 
or find out when your accepted article will be published.  
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